During the past decade, Uppsala University Hospital; Department of Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uppsala University Hospital; Department of Oncology" #1 sponsor was "Alligator Bioscience AB" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Uppsala University" with 2 trials sponsored, "Endocyte" with 1 trials sponsored and "ITM Solucin GmbH" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uppsala University Hospital; Department of Oncology" #1 collaborator was "Uppsala University Hospital" with 3 trials as a collaborator, "AFA Insurance" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Karolinska University Hospital" with 1 trials as a collaborator and "Mundipharma Pte Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Uppsala University Hospital; Department of Oncology" are "Neoplasms" (2 trials), "B Cell Leukemia" (1 trials), "B Cell Lymphoma" (1 trials), "B-Cell Lymphoma" (1 trials) and "B-cell Leukemia" (1 trials). Many other conditions were trialed in "Uppsala University Hospital; Department of Oncology" in a lesser frequency.

Most popular intervention types in "Uppsala University Hospital; Department of Oncology" are "Drug" (8 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT" (1 trials), "177Lu-PSMA-617" (1 trials), "ADC-1013" (1 trials), "ATOR-1017" (1 trials) and "Amino-Acid Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uppsala University Hospital; Department of Oncology" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Uppsala University Hospital; Department of Oncology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Uppsala University Hospital; Department of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uppsala University Hospital; Department of Oncology, 6 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".